16:44:17 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-08-29 Kvartalsrapport 2024-Q2
2024-05-15 Årsstämma 2024
2024-04-25 Bokslutskommuniké 2023
2023-10-11 Extra Bolagsstämma 2023
2023-08-31 Kvartalsrapport 2023-Q2
2023-05-30 Ordinarie utdelning BRAINP 0.00 DKK
2023-05-26 Årsstämma 2023
2023-04-28 Bokslutskommuniké 2022
2022-09-29 Kvartalsrapport 2022-Q2
2022-09-02 Extra Bolagsstämma 2022
2022-05-19 Ordinarie utdelning BRAINP 0.00 DKK
2022-05-18 Årsstämma 2022
2022-04-29 Bokslutskommuniké 2021

Beskrivning

LandDanmark
ListaFirst North Denmark
SektorHälsovård
IndustriVård & Omsorg
Brain+ är verksamma inom läkemedelsbranschen. Bolaget är specialiserade inom forskning och utveckling för behandling av demens och alzheimers. Produktportföljen inkluderar exempelvis kognitiv stimuleringsterapi. Utöver huvudverksamheten erbjuds även service och tillhörande kringtjänster. Verksamheten drivs med störst närvaro inom Europa.
2022-10-11 08:15:32

Copenhagen, Denmark October 11, 2022 - Brain+ A/S (Nasdaq First North: BRAINP)

Brain+ A/S ("Brain+") has upped its investor relations strategy to include a number of new initiatives with the intention to further increase transparency towards investors on the company's business activities and progress. In addition, the company has made an agreement with AG Equity Research AB ("Analyst Group") to undertake commissioned equity research.    

The new IR initiatives are the following:
  • Introduce shorter financial disclosure timelines:
  • Financial report - Full Year, up to one month earlier than 2022
  • Financial report - Half Year, up to one month earlier than 2022

  • Issue quarterly business updates for Q1 and Q3 (first time for Q1 2023)

  • Introduce online bi-annual investor meetings, where the management team will provide live business updates & host Q&A sessions. The first meeting will take place on October 14, 2022 (see below for event details), and the next is planned for after the release of Brain+'s 2022 Full Year report
  • Research coverage by Analyst Group, a Swedish specialist equity research firm. Analyst Group today published its first equity research report on Brain+ and will conduct quarterly updates in addition to interviews and commentary on Brain+ announcements.

Kim Baden-Kristensen, CEO & Co-founder.

"We have now been "live" on Nasdaq First North for a year, and we have had a steep learning curve on how to best communicate with the market. It is of the utmost importance for us to keep our investors as well informed on our company and business as possible, and this strengthening of our IR activities reflects our commitment to that path. The decision to offer commissioned research in both English and Swedish is another initiative to help expand our IR reach and improve transparency beyond Denmark, and particularly for our Swedish neighbors."

Live Investor Update October 14[th] from 13:30-14:00

Brain+ and Gemstone Capital will host a live Investor Update on the 14[th] of October from 13:30-14:00. CEO of Brain+ Kim Baden-Kristensen will provide a general update on the company's activities and outlook (no price-sensitive information will be given at the meeting), and Gemstone Capital will describe the process for the upcoming IPO warrant exercise. This will be followed by a Q&A session.

Please register for the event via the following link (https://bit.ly/3SPE75m):

https://bit.ly/3SPE75m

Contact Information

CEO, Kim Baden-Kristensen + 45 31393317, E-mail: kim@brain-plus.com,Brain+ A/S, Købmagergade 53, 3.